tiprankstipranks
Trending News
More News >
Prelude Therapeutics, Inc. (PRLD)
:PRLD
US Market
Advertisement

Prelude Therapeutics (PRLD) Financial Statements

Compare
146 Followers

Prelude Therapeutics Financial Overview

Prelude Therapeutics's market cap is currently $85.46M. The company's EPS TTM is $-0.41; its P/E ratio is ―; Prelude Therapeutics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Prelude Therapeutics Earnings and Revenue History

Prelude Therapeutics Debt to Assets

Prelude Therapeutics Cash Flow

Prelude Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis